used the CRISPR/Cas9 system to introduce tumor cells heterozygous for the p53 R273H mutant into mice and found that epithelial-mesenchymal transition was increased, and the number of tumor stem cells was increased, thereby promoting tumor formation. This evidence concerns the gene TP53 and neoplasm.